EV/EBITDA
0.49
+0.10+25.64%
5 min ago
Summary
- As of February 26, 2025, LXEO EV/EBITDA is 0.49, with a rise of +0.10 (+25.64%) during the most recent trading day.
- Over the past year, LXEO EV/EBITDA has increased by +5.60 (+109.59%).
- LXEO EV/EBITDA is now at all-time high.
Performance
LXEO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LXEO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +25.6% | -26.1% | -7.6% |
| 1 m1 month | +208.9% | -209.4% | -43.0% |
| 3 m3 months | +140.2% | -140.4% | -57.8% |
| 6 m6 months | +117.6% | -119.8% | -71.9% |
| ytdytd | +158.3% | -158.4% | -51.7% |
| 1 y1 year | +109.6% | -112.6% | -80.7% |
| 5 y5 years | - | - | - |
LXEO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.61 | +180.3% | |
| 3 m | 3-month | 0.49 | at high | -1.56 | +131.4% |
| 6 m | 6-month | 0.49 | at high | -3.12 | +115.7% |
| 1 y | 1-year | 0.49 | at high | -6.45 | +107.6% |
| 3 y | 3-year | 0.49 | at high | -6.45 | +107.6% |
| 5 y | 5-year | 0.49 | at high | -6.45 | +107.6% |
| alltime | all time | 0.49 | at high | -6.45 | +107.6% |
Lexeo Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.49(-158.3%) |
| Date | Value |
|---|---|
| 2024 | -0.84(-78.2%) |
| 2023 | -3.85 |
FAQ
- What is Lexeo Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lexeo Therapeutics?
- What is LXEO EV/EBITDA year-to-date change?
- What is Lexeo Therapeutics EV/EBITDA year-on-year change?
What is Lexeo Therapeutics EV/EBITDA?
The current EV/EBITDA of LXEO is 0.49
What is the all time high EV/EBITDA for Lexeo Therapeutics?
Lexeo Therapeutics all-time high EV/EBITDA is 0.49
What is LXEO EV/EBITDA year-to-date change?
Lexeo Therapeutics EV/EBITDA has changed by +1.33 (+158.33%) since the beginning of the year
What is Lexeo Therapeutics EV/EBITDA year-on-year change?
Over the past year, LXEO EV/EBITDA has changed by +5.60 (+109.59%)